Tofacitinib and Analogs as Inhibitors of the Histone Kinase Prk1 (Pkn1)
- 30 August 2016
- journal article
- research article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 8 (13) , 1537-1551
Abstract
Aim: The histone kinase PRK1 has been identified as a potential target to combat prostate cancer but selective PRK1 inhibitors are lacking. The US FDA -approved JAK1–3 inhibitor tofacitinib also potently inhibits PRK1 in vitro. Results: We show that tofacitinib also inhibits PRK1 in a cellular setting. Using tofacitinib as a starting point for structure–activity relationship studies, we identified a more potent and another more selective PRK1 inhibitor compared with tofacitinib. Furthermore, we found two potential PRK1/JAK3-selectivity hotspots. Conclusion: The identified inhibitors and the selectivity hotspots lay the basis for the development of selective PRK1 inhibitors. The identification of PRK1, but also of other cellular tofacitinib targets, has implications on its clinical use and on future development of tofacitinib-like JAK inhibitors.Keywords
Funding Information
- Collaborative Research Center CRC 992 MEDEP (ERC AdGrant 322844)
This publication has 48 references indexed in Scilit:
- Protein kinase C-related kinase 1 and 2 play an essential role in thromboxane-mediated neoplastic responses in prostate cancerOncotarget, 2015
- PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cellsOncotarget, 2014
- Differential Binding of RhoA, RhoB, and RhoC to Protein Kinase C-Related Kinase (PRK) Isoforms PRK1, PRK2, and PRK3: PRKs Have the Highest Affinity for RhoBBiochemistry, 2013
- Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulationNature Cell Biology, 2007
- The complex language of chromatin regulation during transcriptionNature, 2007
- Chromatin Modifications and Their FunctionCell, 2007
- The Structural Basis of Rho Effector Recognition Revealed by the Crystal Structure of Human RhoA Complexed with the Effector Domain of PKN/PRK1Molecular Cell, 1999
- Resolution and Reconstitution of Succinate-Ubiquinone Reductase from Escherichia coliJournal of Biological Chemistry, 1997
- Activation of PRK1 by Phosphatidylinositol 4,5-Bisphosphate and Phosphatidylinositol 3,4,5-TrisphosphateJournal of Biological Chemistry, 1995
- Expression, purification and characterization of the ubiquitous protein kinase C-related kinase 1Biochemical Journal, 1995